Statins Reverse Doxorubicin Resistance in Mesothelioma Cells
July 13th, 2006
Statins reverse doxorubicin resistance in human malignant mesothelioma cells in culture, a finding that may lead to new clinical strategies to improve doxorubicin efficacy in this hard to treat cancer.